Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Meeting ReportOncology, Basic and Translational - Early Phase (Phase 0 or I) human studies

Collagen type I PET/MRI for evaluation of treatment response in pancreatic cancer; results of pre-clinical and first in-human translational studies

Shadi Esfahani, Hua Ma, Shriya Krishna, Sergey Shuvaev, Bahar Ataeinia, Nicholas Rotile, Jonah Weigand Whittier, Iris Zhou, Ciprian Catana, Onofrio Catalano, David Ting, Umar Mahmood, Michael Lanuti, Motaz Qadan, Aparna Parikh, Colin Weekes, Kenneth Tanabe, Theodore Hong and Peter Caravan
Journal of Nuclear Medicine June 2023, 64 (supplement 1) P625;
Shadi Esfahani
1Massachusetts General Hospital
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hua Ma
1Massachusetts General Hospital
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Shriya Krishna
1Massachusetts General Hospital
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sergey Shuvaev
1Massachusetts General Hospital
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Bahar Ataeinia
2MGH
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Nicholas Rotile
1Massachusetts General Hospital
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jonah Weigand Whittier
1Massachusetts General Hospital
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Iris Zhou
1Massachusetts General Hospital
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ciprian Catana
3Martinos Center, MGH
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Onofrio Catalano
1Massachusetts General Hospital
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
David Ting
1Massachusetts General Hospital
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Umar Mahmood
1Massachusetts General Hospital
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Michael Lanuti
1Massachusetts General Hospital
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Motaz Qadan
1Massachusetts General Hospital
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Aparna Parikh
1Massachusetts General Hospital
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Colin Weekes
1Massachusetts General Hospital
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kenneth Tanabe
1Massachusetts General Hospital
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Theodore Hong
1Massachusetts General Hospital
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Peter Caravan
1Massachusetts General Hospital
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
Loading

Article Figures & Data

Figures

  • Figure
    • Download figure
    • Open in new tab
    • Download powerpoint
  • Figure
    • Download figure
    • Open in new tab
    • Download powerpoint
Previous
Back to top

In this issue

Journal of Nuclear Medicine
Vol. 64, Issue supplement 1
June 1, 2023
  • Table of Contents
  • Index by author
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Collagen type I PET/MRI for evaluation of treatment response in pancreatic cancer; results of pre-clinical and first in-human translational studies
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Collagen type I PET/MRI for evaluation of treatment response in pancreatic cancer; results of pre-clinical and first in-human translational studies
Shadi Esfahani, Hua Ma, Shriya Krishna, Sergey Shuvaev, Bahar Ataeinia, Nicholas Rotile, Jonah Weigand Whittier, Iris Zhou, Ciprian Catana, Onofrio Catalano, David Ting, Umar Mahmood, Michael Lanuti, Motaz Qadan, Aparna Parikh, Colin Weekes, Kenneth Tanabe, Theodore Hong, Peter Caravan
Journal of Nuclear Medicine Jun 2023, 64 (supplement 1) P625;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Collagen type I PET/MRI for evaluation of treatment response in pancreatic cancer; results of pre-clinical and first in-human translational studies
Shadi Esfahani, Hua Ma, Shriya Krishna, Sergey Shuvaev, Bahar Ataeinia, Nicholas Rotile, Jonah Weigand Whittier, Iris Zhou, Ciprian Catana, Onofrio Catalano, David Ting, Umar Mahmood, Michael Lanuti, Motaz Qadan, Aparna Parikh, Colin Weekes, Kenneth Tanabe, Theodore Hong, Peter Caravan
Journal of Nuclear Medicine Jun 2023, 64 (supplement 1) P625;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Figures & Data
  • Info & Metrics

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • Al18F-NOTA-HER2-BCH affibody PET imaging accurately map HER2 positive lesions of breast cancer
  • Molecular imaging of acute radiation-induced esophagitis using [18F]AlF labeled polypeptide targeting C-X-C-chemokine-receptor-type-4
  • 212Pb-VMT-α-NET Targeted Alpha Therapy in Metastatic Neuroendocrine Tumors: First in Human study on Safety and Efficacy
Show more Oncology, Basic and Translational - Early Phase (Phase 0 or I) human studies

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire